The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study

<i>Background and Objectives:</i> This study aimed to evaluate whether the addition of hypomethylating agents (HMA) to low-intensity chemotherapy can enhance the clinical efficacy of induction treatment for elderly acute myeloid leukemia (AML) patients who are unsuitable for standard induction thera...

Descripció completa

Dades bibliogràfiques

Autors principals:	Dan Liu, Xiaoyu Wang, Juan Tong, Li Zhou, Erling Chen, Ziwei Zhou, Lei Xue, Xuhan Zhang, Guangyu Sun, Changcheng Zheng
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2023-01-01
Col·lecció:	Medicina
Matèries:	acute myeloid leukemia elderly patients low intensity chemotherapy hypomethylating agents complete remission survival
Accés en línia:	https://www.mdpi.com/1648-9144/59/1/114
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!